Physio-Control, a wholly-owned subsidiary of Medtronic, has received 510(k) clearance from the US Food and Drug Administration (FDA) to market Lifenet System 5.0 within the US.
Lifenet 5.0 is the latest version of Physio-Control’s web-based data network, providing emergency medical services (EMS) and hospital care teams with a suite of new tools and capabilities to help improve patient outcomes, trim operational costs, and streamline equipment management.
The new features available in Lifenet 5.0 include Lifenet Consult, Lifenet OnePush, Lifenet ePCR Delivery, Lifenet Asset and enhanced data integration.
Physio-Control president Brian Webster said that Lifenet 5.0 expands on their vision of a completely connected product line, allowing for easy sharing of clinical data as well as simplifying their customers’ operations.
“The significant investments we have made in the Lifenet network has built a solid infrastructure for sharing important data that also serves as a ‘backbone’ for providing future capabilities to customers,” Webster said.